/C O R R E C T I O N -- Alora Pharmaceuticals, LLC/
In the news release, Once-daily RELEXXII® (methylphenidate hydrochloride extended-release tablet) supports Attention Deficit Hyperactivity Disorder (ADHD) Awareness Month, issued 06-Oct-2026 by Alora Pharmaceuticals, LLC over PR Newswire, we are advised by the company that changes have...
Read original article on All News Releases →